Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669148 · ClinicalTrials.gov registry record · NA
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 496
- Enrollment target
NCT01669148: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01669148 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 496 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01669148, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 496 participants
- Enrollment target
Study Summary
The primary hypothesis to be tested is: The detection of breast cancer will be increased with tomosynthesis (3D) imaging
Interventions
- DEVICE Conventional
- DEVICE Tomosynthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 496 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01669148
The ClinicalTrials.gov registry entry for NCT01669148 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 496 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conventional is the first listed.
NCT01669148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01669148 about?
NCT01669148 is a clinical study titled "Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography". The primary hypothesis to be tested is: The detection of breast cancer will be increased with tomosynthesis (3D) imaging
What is the current status of trial NCT01669148?
This trial is currently completed. It is a NA study. The enrollment target is 496 participants. The study started on 2007-11. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01669148?
The interventions under investigation include: Conventional (DEVICE), Tomosynthesis (DEVICE).
Who is sponsoring clinical trial NCT01669148?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.